We are live on ! Find out more
ORC

Orchid Island Capital

15 hedge funds and large institutions have $10.4M invested in Orchid Island Capital in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

647% more capital invested

Capital invested by funds: $1.39M → $10.4M (+$8.97M)

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

67% more funds holding

Funds holding: 915 (+6)

1.38% more ownership

Funds ownership: 0.64%2.03% (+1.4%)

Holders
15
Holders Change
+6
Holders Change %
+66.67%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
5
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

ORC Hedge Fund Activity: Q1 2014 in Review

15 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Orchid Island Capital (ORC) for Q1 2014, worth a combined $10.4M — up 647% from $1.39M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ORC positions and 1 closed out — a net gain of 6 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $2.03M. The largest seller was Tower Research Capital (TRC), cutting an estimated $317.

  • 15 institutional investors held Orchid Island Capital (ORC) as of Q1 2014, up from 9 in Q4 2013.
  • Funds reported $10.4M of Orchid Island Capital stock for Q1 2014, up 647% quarter-over-quarter.
  • 7 funds opened new Orchid Island Capital positions in Q1 2014 and 1 closed out, a net change of +6 holders.
  • The largest Orchid Island Capital buyer in Q1 2014 was Renaissance Technologies, an estimated $2.03M added.
  • The largest Orchid Island Capital seller in Q1 2014 was Tower Research Capital (TRC), an estimated $317 sold.

Based on aggregated 13F filings for Q1 2014.